> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 21 State AGs Urge FDA OK of OTC Birth Control
- URL: https://www.fdaweb.com/21-state-ags-urge-fda-ok-of-otc-birth-control/
- Published: 2022-11-04T12:00:00.000Z
- Updated: 2026-09-14T18:05:13.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5153133

Twenty-one state attorneys general (AGs) led by California's **Rob Bonta** are urging FDA to approve over-the-counter (OTC) birth control pills. In an 11/4 letter to FDA commissioner **Robert Califf**, the AGs stress the need to improve access to birth control for millions of people in in this country.

“Now, more than ever, ensuring access to birth control is crucial,” the AGs write, noting that an NDA for Opill was submitted in July by HRA Pharma, shortly after the Supreme Court overturned Roe v. Wade. They say, “many states have banned or restricted abortion care, narrowing the choices for those seeking reproductive care and making access to birth control even more critical nationwide.” 

Meanwhile, FDA recently postponed an 11/18 joint meeting of its Nonprescription Drugs Advisory Committee and Obstetrics, Reproductive and Urologic Drugs Advisory Committee, which was being convened to discuss the OTC birth control application. The agency says the postponement will provide more time to review new information submitted by the company. If approved, Opill would be the first over-the-counter birth control pill in the U.S. The progestin-only daily birth control pill (also referred to as a mini pill or non-estrogen pill) was first approved in 1973.